Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05956366
Other study ID # H-17022391
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 1, 2018
Est. completion date December 31, 2037

Study information

Verified date March 2024
Source Mental Health Services in the Capital Region, Denmark
Contact Mette Bentz, PhD
Phone +45 38 64 10 35
Email mette.bentz@regionh.dk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This research project aims to characterize a naturalistic cohort of children and adolescents with eating disorders in terms of biological, psychological and psychopathological features. Further, the project will examine the effectiveness of treatment, the determinants of treatment outcome and the course of treatment response for children and adolescents with eating disorders (ED), treated in a generic specialist child and adolescent mental health service. The first choice of treatment is outpatient family-based treatment (FBT), which has documented effect for anorexia nervosa and bulimia nervosa. However, a subgroup of young persons with eating disorders does not respond sufficiently to this treatment, and evidence concerning effective treatment for children and adolescents with atypical eating disorders is still lacking. Further, treatment effectiveness for children and adolescents in a Danish naturalistic setting has never been examined.


Description:

The overall aim is to assess associations between patient characteristics and treatment response across the spectrum of eating disorders to identify, which patients benefit from family based treatment, and which patients possibly would need other kinds of treatment or more intensive care. Research questions: 1. Which patient and family characteristics predict faster recovery from ED in childhood and adolescence? 2. Which patient and family characteristics predict intensification of treatment in the forms of day hospital or full hospitalization? 3. At which time point can recovery be predicted based on information from initial assessment and/or assessment during the course of treatment? 4. Which patient and family characteristics (e.g. patterns of comorbid symptoms) are common in those not responding well to treatment within each diagnostic category? 5. How many young patients migrate between ED diagnoses, and what characterizes these patients? 6. Studies on treatment effectiveness for EDNOS in children and adolescents are still lacking. Hence, an important research question of this study is whether family based treatment for EDNOS is effective and is perceived as helpful by patients and families? In addition, the project will seek to answer the following: 7. Is treatment effectiveness in The Capital Region of Denmark (BUC) comparable to published results from other countries in the same age group?


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date December 31, 2037
Est. primary completion date December 31, 2035
Accepts healthy volunteers No
Gender All
Age group 7 Years to 17 Years
Eligibility Inclusion Criteria: - begin treatment for eating disorder Exclusion Criteria: - lack of informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Family-based treatment
Open-end family therapy ad modum The Maudsley model

Locations

Country Name City State
Denmark Child and Adolescent Mental Health Care Center Copenhagen

Sponsors (1)

Lead Sponsor Collaborator
Mental Health Services in the Capital Region, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary proportion of participants with weight normalisation at or above 95% of ideal BMI adjusted for age and gender, based on the individual´s prior growth trajectory. BMI is calculated as weight in kg/(height in meters*height in meters), and percentage if ideal BMI adjusted for age and gender is based on published, standardized growth curves from Danish children and adolescents through treatment completion an average of 1 year
Primary proportion of participants with weight normalisation at or above 95% of ideal BMI adjusted for age and gender, based on the individual´s prior growth trajectory. BMI is calculated as weight in kg/(height in meters*height in meters), and percentage if ideal BMI adjusted for age and gender is based on published, standardized growth curves from Danish children and adolescents 2.5 years after treatment completion
Primary proportion of participants with weight normalisation at or above 95% of ideal BMI adjusted for age and gender, based on the individual´s prior growth trajectory. BMI is calculated as weight in kg/(height in meters*height in meters), and percentage if ideal BMI adjusted for age and gender is based on published, standardized growth curves from Danish children and adolescents 5 years after treatment completion
Primary proportion of participants with weight normalisation at or above 95% of ideal BMI adjusted for age and gender, based on the individual´s prior growth trajectory. BMI is calculated as weight in kg/(height in meters*height in meters), and percentage if ideal BMI adjusted for age and gender is based on published, standardized growth curves from Danish children and adolescents 7.5 years after treatment completion
Primary proportion of participants with weight normalisation at or above 95% of ideal BMI adjusted for age and gender, based on the individual´s prior growth trajectory. BMI is calculated as weight in kg/(height in meters*height in meters), and percentage if ideal BMI adjusted for age and gender is based on published, standardized growth curves from Danish children and adolescents 10 years after treatment completion
Primary proportion of participants with absence of eating disordered behaviors absence for 4 weeks (according to diagnostic questions if Eating Disorder Examination (EDE). through treatment completion an average of 1 year
Primary proportion of participants with absence of eating disordered behaviors absence for 4 weeks (according to diagnostic questions if Eating Disorder Examination (EDE). 2.5 years after treatment completion
Primary proportion of participants with absence of eating disordered behaviors absence for 4 weeks (according to diagnostic questions if Eating Disorder Examination (EDE). 5 years after treatment completion
Primary proportion of participants with absence of eating disordered behaviors absence for 4 weeks (according to diagnostic questions if Eating Disorder Examination (EDE). 7.5 years after treatment completion
Primary proportion of participants with absence of eating disordered behaviors absence for 4 weeks (according to diagnostic questions if Eating Disorder Examination (EDE). 10 years after treatment completion
See also
  Status Clinical Trial Phase
Recruiting NCT05656859 - Prevalence of Eating Disorders Among Patients in the Department of Health Promotion
Completed NCT04085861 - Mental Health in Dancers; an Intervention Study N/A
Recruiting NCT05651295 - A Precision Medicine Approach to Target Engagement for Emotion Regulation N/A
Enrolling by invitation NCT04174703 - Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing N/A
Terminated NCT04278755 - Binge Eating & Birth Control Phase 2
Withdrawn NCT03050632 - Effects of Cognitive and Emotional Functioning on Treatment Outcomes N/A
Completed NCT02484794 - Augmenting Specialty Eating Disorder Clinical Treatment With a Smartphone Application N/A
Completed NCT02567890 - Swedish Body Project for Prevention of Eating Disorders N/A
Completed NCT02252822 - Improving Treatment Engagement for Adolescents With Bulimia Nervosa N/A
Completed NCT02021344 - Mental Health First Aid for College Students N/A
Completed NCT00601354 - Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder N/A
Completed NCT00418977 - Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents N/A
Completed NCT00304187 - Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa Phase 2
Completed NCT00733525 - Effectiveness of Stepped Care Versus Best Available Care for Bulimia Nervosa N/A
Active, not recruiting NCT04779216 - Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa Phase 3
Completed NCT04433663 - Eating Disorders, Self Regulation and Mentalization N/A
Recruiting NCT05509257 - Naltrexone Neuroimaging in Teens With Eating Disorders Early Phase 1
Completed NCT04509531 - Building Resilience in Cyberbullying Victims N/A
Recruiting NCT05730348 - Mealtime Anxiety in Eating Disorders
Enrolling by invitation NCT05814653 - A Study to Evaluate Primary Care Treatment for Adolescent Eating Disorders N/A